Genetic Testing — Molecular Codes, Properly Covered

Proven Results

• 48% Average Revenue Increase
• 93.1% Clean Claim Rate
• 55% Reduction in Denials
• 26 Days Faster Payment Collection

Common Billing Challenges

High-Complexity CPT Codes

Molecular and genetic testing uses complex multi-tiered CPT codes with stacking rules and component billing requirements.

Medical Necessity Documentation

Genetic tests require extensive medical necessity documentation including family history, clinical indications, and genetic counseling.

Prior Authorization Requirements

Most genetic and molecular tests require prior authorization with detailed clinical justification and supporting documentation.

Payer-Specific Policies

Each payer has unique coverage policies, testing criteria, and reimbursement rates for genetic tests.

Panel Bundling Complexity

Multi-gene panels require proper bundling of individual genes versus comprehensive panel codes.

Hereditary Testing Criteria

Hereditary cancer and disease testing has strict clinical criteria that must be met for coverage approval.

Our Solutions

Molecular Billing Specialists

Our team includes certified coders with specialized training in molecular diagnostics and genetic testing billing.

• Expert CPT code selection for genetic tests
• Proper panel bundling strategies
• Payer-specific coding knowledge
• Reduced coding errors and denials

Medical Necessity Validation

Comprehensive review of test orders against payer-specific medical necessity criteria before claim submission.

• Pre-claim medical necessity review
• Family history documentation
• Clinical indication validation
• ABN management when needed

Prior Authorization Management

Dedicated PA team with expertise in genetic testing authorizations and payer requirements.

• Faster authorization approvals
• Clinical documentation support
• Genetic counseling coordination
• Appeal support for denials

Payer Policy Monitoring

Continuous monitoring of payer coverage policies and testing criteria for all genetic and molecular tests.

• Real-time policy updates
• Coverage determination support
• Testing criteria validation
• Reimbursement optimization

Specialized Services

Genetic Panel Billing

Expert billing for multi-gene panels including hereditary cancer, cardiac, and neurology panels.

• Cancer panel billing
• Cardiac genetic testing
• Neurology panels
• Comprehensive genomics

Molecular Diagnostics

Specialized billing for molecular testing including PCR, sequencing, and chromosomal analysis.

• Next-gen sequencing
• PCR testing
• Chromosomal microarray
• FISH analysis

Cancer Genomics

Complete billing for oncology molecular testing including tumor profiling and liquid biopsies.

• Tumor profiling
• Liquid biopsy
• Somatic mutation testing
• Companion diagnostics

Hereditary Testing

Expert billing for hereditary disease and carrier screening with proper documentation.

• Hereditary cancer
• Carrier screening
• Prenatal testing
• Pharmacogenomics

Common CPT Codes Reference

Key codes include 81162 (BRCA1, BRCA2 (hereditary breast and ovarian cancer) gene ana), 81201 (APC gene analysis, full sequence), 81479 (Unlisted molecular pathology procedure), 81435 (Hereditary colon cancer disorders, Lynch syndrome, full sequ), 81519 (Oncology (breast), mRNA gene expression profiling (Oncotype ), 81518 (Oncology (breast) mRNA, gene expression profiling (MammaPrin), 81336 (SMN1 gene dosage/deletion analysis), 81220 (CFTR gene analysis, common variants), 81302 (MECP2 gene analysis, full sequence), 81408 (Molecular pathology, level 9 (highest complexity)). Proper code selection requires understanding of bundling rules, NCCI edits, and modifier usage.

Expert Billing Insights

Hereditary Cancer Testing: Criteria, Coverage, and Genetic Counseling

Hereditary cancer genetic testing (BRCA, Lynch syndrome, PALB2) is covered by Medicare and most commercial payers when specific clinical criteria are met. For BRCA testing, criteria include personal or family history of breast cancer at young age (<45), bilateral breast cancer, triple-negative breast cancer under 60, or two first-degree relatives with breast or ovarian cancer. Documentation must clearly reference which criteria support testing. Genetic counseling is a prerequisite for many payers and may be separately billable.

• BRCA criteria: document personal/family history meeting NCCN hereditary cancer guidelines
• Lynch syndrome (81435): Amsterdam II or Bethesda criteria — document MMR immunohistochemistry
• Genetic counseling: 96040 (medical genetics counseling) — required by some payers pre-testing
• Cascade testing: family members of positive probands may qualify for targeted testing at lower cost

Tumor Profiling and Genomic Testing: Prior Authorization and LCD Requirements

Tumor genomic profiling tests (Oncotype DX, MammaPrint, Foundation One CDx, Guardant360) are among the most expensive and most tightly regulated laboratory tests in medicine. Medicare coverage for these tests is governed by LCDs (L36510, L38144) that specify tumor type, stage, and treatment intent criteria. Companion diagnostic tests linked to specific targeted therapies (PD-L1, HER2, EGFR, ALK, BRAF) are generally covered when the associated targeted therapy is indicated. Prior authorization from commercial payers is nearly universal.

• Oncotype DX: covered for ER+, HER2-, early-stage breast cancer under Medicare LCD L36510
• Foundation One CDx: broad solid tumor panel — Medicare covers for specific tumor types with CDx claims
• Liquid biopsy (Guardant360, FoundationOne Liquid): coverage expanding for NSCLC and select cancers
• Document: tumor type, stage, hormone receptor status, treatment plan, and therapeutic decision expected

GINA and Privacy Considerations in Genetic Billing

The Genetic Information Nondiscrimination Act (GINA) prohibits health insurers from using genetic information as a basis for coverage decisions or premium setting. However, GINA does not protect against discrimination in life insurance, disability insurance, or long-term care insurance — patients should be counseled about these limitations before testing. Medical billing for genetic tests must use ICD-10 codes appropriately — billing a predictive genetic test for an unaffected patient with a family history code (Z-code) is different from billing a diagnostic test in an affected patient.

• GINA protection: health insurance cannot use genetic results for coverage, rates, or enrollment
• Z-codes for predictive genetic testing: Z13.xx (screening) or Z84.89 (family history)
• Diagnostic genetic tests: use the condition code (e.g., C50.xx for breast cancer, K63.xx for Lynch) when disease is confirmed
• Document whether testing is diagnostic (disease present) vs. predictive (risk assessment) — affects LCD coverage

Payer-Specific Billing Tips

Medicare

• Hereditary cancer testing LCDs: L36522 (MolDX) for BRCA and Lynch — review criteria carefully
• Tumor profiling LCDs: vary by MAC; verify through your regional MAC (Palmetto, Noridian, etc.)
• Non-invasive prenatal testing (NIPT): not currently covered by Medicare — patient self-pay
• Pharmacogenomics: CMS coverage expanding for select PGx tests tied to specific drug decisions

Medicaid

• Medicaid genetic testing: covered for medically necessary indications — prior auth required
• Newborn screening: state-mandated panels are covered; expanded panels may be patient-pay
• Pediatric genetic testing (EPSDT): comprehensive coverage for developmental delay, intellectual disability
• State Medicaid managed care: genetic test coverage policies may differ from fee-for-service Medicaid

Commercial Payers

• Prior authorization universal for expensive genomic panels — submit clinical justification with request
• Preferred lab networks: many commercial plans limit genetic testing to contracted reference labs
• Oncotype DX and MammaPrint: verify payer-specific clinical coverage criteria — may differ from Medicare
• Pharmacogenomics: coverage expanding but variable — verify per-plan for each specific test

Genetic Counseling Billing

• Genetic counseling: 96040 — billable by licensed genetic counselors or physicians
• Prenatal genetic counseling: covered by most payers for advanced maternal age or prior genetic condition
• Telegenetics: genetic counseling via telehealth increasingly available — verify per-payer
• Patient financial counseling before testing: explain out-of-pocket costs before ordering expensive panels

Key Services

• genetic testing billing
• genomic billing
• molecular diagnostics billing
• genetic counseling billing
• DNA testing billing